Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril/valsartan vs valsartan in peritoneal dialysis patients with heart failure
ChiCTR2000039561Phase 4Recruiting
- Sponsor
- Department of Nephrology, Affiliated Hospital of Nantong University
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of sacubitril + valsartan in heart failure (HF) and chronic kidney disease (CKD) (2 arms), sponsored by Department of Nephrology, Affiliated Hospital of Nantong University. Primary endpoints: sST2, BNP and 4 more. Started Nov 2020; status: recruiting.
02
Drugs
sacubitril + valsartan
03
Conditions
heart failure (HF)chronic kidney disease (CKD)
Beyond the preview
Go deeper on ChiCTR2000039561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039561.